These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17565739)

  • 1. Increased expression of the inflammatory protein YKL-40 in precancers of the breast.
    Qin W; Zhu W; Schlatter L; Miick R; Loy TS; Atasoy U; Hewett JE; Sauter ER
    Int J Cancer; 2007 Oct; 121(7):1536-42. PubMed ID: 17565739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk.
    Sauter ER; Lininger J; Magklara A; Hewett JE; Diamandis EP
    Int J Cancer; 2004 Feb; 108(4):588-91. PubMed ID: 14696124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer.
    Kim SH; Das K; Noreen S; Coffman F; Hameed M
    World J Surg Oncol; 2007 Feb; 5():17. PubMed ID: 17286869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer.
    Yamac D; Ozturk B; Coskun U; Tekin E; Sancak B; Yildiz R; Atalay C
    Adv Ther; 2008 Aug; 25(8):801-9. PubMed ID: 18670741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer.
    Jensen BV; Johansen JS; Price PA
    Clin Cancer Res; 2003 Oct; 9(12):4423-34. PubMed ID: 14555515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival.
    Johansen JS; Christensen IJ; Riisbro R; Greenall M; Han C; Price PA; Smith K; Brünner N; Harris AL
    Breast Cancer Res Treat; 2003 Jul; 80(1):15-21. PubMed ID: 12889595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer.
    Sauter ER; Garofalo C; Hewett J; Hewett JE; Morelli C; Surmacz E
    Horm Metab Res; 2004 May; 36(5):336-40. PubMed ID: 15156414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer.
    Sauter ER; Tichansky DS; Chervoneva I; Diamandis EP
    Environ Health Perspect; 2002 Mar; 110(3):241-6. PubMed ID: 11882474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YKL-40 expression in benign and malignant lesions of the breast: a methodologic study.
    Roslind A; Johansen JS; Junker N; Nielsen DL; Dzaferi H; Price PA; Balslev E
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):371-81. PubMed ID: 18091378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum YKL-40 in risk assessment for colorectal cancer: a prospective study of 4,496 subjects at risk of colorectal cancer.
    Johansen JS; Christensen IJ; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Brünner N; Nielsen HJ
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):621-6. PubMed ID: 25597749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma.
    Schmidt H; Johansen JS; Gehl J; Geertsen PF; Fode K; von der Maase H
    Cancer; 2006 Mar; 106(5):1130-9. PubMed ID: 16456816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer.
    Roslind A; Knoop AS; Jensen MB; Johansen JS; Nielsen DL; Price PA; Balslev E
    Breast Cancer Res Treat; 2008 Nov; 112(2):275-85. PubMed ID: 18157633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection and prognosis of ovarian cancer using serum YKL-40.
    Dupont J; Tanwar MK; Thaler HT; Fleisher M; Kauff N; Hensley ML; Sabbatini P; Anderson S; Aghajanian C; Holland EC; Spriggs DR
    J Clin Oncol; 2004 Aug; 22(16):3330-9. PubMed ID: 15310777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia.
    Kucur M; Isman FK; Balci C; Onal B; Hacibekiroglu M; Ozkan F; Ozkan A
    Urol Oncol; 2008; 26(1):47-52. PubMed ID: 18190830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.
    Diefenbach CS; Shah Z; Iasonos A; Barakat RR; Levine DA; Aghajanian C; Sabbatini P; Hensley ML; Konner J; Tew W; Spriggs D; Fleisher M; Thaler H; Dupont J
    Gynecol Oncol; 2007 Feb; 104(2):435-42. PubMed ID: 17023034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid.
    Alexander H; Stegner AL; Wagner-Mann C; Du Bois GC; Alexander S; Sauter ER
    Clin Cancer Res; 2004 Nov; 10(22):7500-10. PubMed ID: 15569980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased shedding of soluble fragments of P-cadherin in nipple aspirate fluids from women with breast cancer.
    Mannello F; Tonti GA; Medda V; Pederzoli A; Sauter ER
    Cancer Sci; 2008 Nov; 99(11):2160-9. PubMed ID: 18811693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nipple aspirate fluid color is associated with breast cancer.
    Sauter ER; Winn JN; Dale PS; Wagner-Mann C
    Cancer Detect Prev; 2006; 30(4):322-8. PubMed ID: 16963197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2.
    Mannello F; Qin W; Zhu W; Fabbri L; Tonti GA; Sauter ER
    Breast Cancer Res Treat; 2008 Sep; 111(2):209-18. PubMed ID: 17932742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma.
    Biggar RJ; Johansen JS; Smedby KE; Rostgaard K; Chang ET; Adami HO; Glimelius B; Molin D; Hamilton-Dutoit S; Melbye M; Hjalgrim H
    Clin Cancer Res; 2008 Nov; 14(21):6974-8. PubMed ID: 18980992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.